|
- Coronavirus disease (COVID-19) - World Health Organization (WHO)
People with severe disease and those needing hospital treatment should receive treatment as soon as possible The consequences of severe COVID-19 include death, respiratory failure, sepsis, thromboembolism (blood clots), and multiorgan failure, including injury of the heart, liver or kidneys
- WHO statement on attack on Al Ahli Arab Hospital and reported large . . .
WHO strongly condemns the attack on Al Ahli Arab Hospital in the north of the Gaza Strip The hospital was operational, with patients, health and care givers, and internally displaced people sheltering there Early reports indicate hundreds of fatalities and injuries The hospital was one of 20 in the north of the Gaza Strip facing evacuation orders from the Israeli military The order for
- Preeclampsia - World Health Organization (WHO)
Datos y cifras A nivel mundial, la tasa de preeclampsia por embarazo se sitúa entre el 2 % y el 8 % Cada año se registran alrededor de 46 000 muertes maternas y 500 000 muertes fetales o neonatales debido a este trastorno (1)
- Reference Classifications - World Health Organization (WHO)
Benefits of WHO-FIC ICD-11, ICF and ICHI are key for effective knowledge representation and data transfer WHO Family of International Classifications (WHO-FIC) allows all healthcare workers (and patients) to communicate using one (technical) language
- Primary health care - World Health Organization (WHO)
Primary health care (PHC) addresses the majority of a person’s health needs throughout their lifetime This includes physical, mental and social well-being and it is people-centred rather than disease-centred PHC is a whole-of-society approach that includes health promotion, disease prevention, treatment, rehabilitation and palliative care
- WHO Mortality Database - WHO - World Health Organization (WHO)
Users should read carefully the "documentation zip" file which contains new information added You are being provided herewith the original detailed data files which comprise the WHO Mortality DataBase (MDB)
- Health products policy and standards - World Health Organization (WHO)
Good Manufacturing Practices (GMP, also referred to as 'cGMP' or 'current Good Manufacturing Practice') is the aspect of quality assurance that ensures that medicinal products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the product specification
- World Health Organization (WHO)
WHO EPI-WIN Webinar: new guidelines for mpox clinical management and infection prevention and control 23 June 2025 13:00 – 14:15 CET
|
|
|